Stonepine Capital Management LLC 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:23 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 7,594,166 9.990% | 4,323,066 (+132.16%) | Filing |
| 2026-02-02 8:01 pm Purchase | 2026-01-29 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 3,271,100 10.600% | 240,174 (+7.92%) | Filing |
| 2025-12-16 4:04 pm Purchase | 2025-12-10 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 3,030,926 9.900% | 3,030,926 (New Position) | Filing |